Health Product InfoWatch, August 2026
Content: Product monograph update: Tecfidera (dimethyl fumarate); Notice of market authorization with conditions: Ojemda (tovorafenib)
Monthly Update to the Canada Vigilance adverse reaction online database
he data presented in the Canada Vigilance Adverse Reaction Online Database has been updated and now includes information received by Health Canada up to April 30, 2026. The next update of data is scheduled for early September 2026.
Monthly update to the list of new safety and effectiveness reviews for health products
The list of new safety and effectiveness reviews has been updated and now includes safety reviews initiated between June 1 and 30, 2026. The next update is scheduled for September 2026.
Health Product InfoWatch, July 2026
Safety brief: Announcement: Ministerial Reliance Order; Vaccine safety summary: 2025 AEFI data; Safety brief: Carbamazepine and oxcarbazepine oral suspensions and the risk of propylene glycol toxicity.